IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Galmed Pharmaceuticals LTD (GLMD)

CUSIP: M47238956 | 2 institutional holders

Quarters

Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile